VALUE-Dx’s Closing Conference

VALUE-Dx officially ends on 30 September 2024, but until that time, project partners will continue to go to all lengths to generate ground-breaking and much needed insights into the value of diagnostics to improve antimicrobial prescription. These findings will be presented in a two-day Closing Conference in Valencia on 4 and 5 September 2024.

The outcomes of VALUE-Dx will be of particular interest for a wide range of stakeholders, including policy makers, public health officials, regulators and patient organisations. VALUE-Dx partners are therefore developing a tailored conference programme to translate the major study results in recommendations, concrete conclusions and food for thought. To stimulate interaction and dialogue, the conference will offer a balanced mixture of lectures and panel discussions. The programme will be finalized in the weeks to come, but here are already some of the highlights:

  1. Main findings and implications for practice, policy and research of the PRUDENCE and ADEQUATE studies
  2. Health economics analysis and implications of the clinical trials
  3. Policy recommendations related to funding, pricing, and procurement to enhance the use of Point-of-Care Tests for CA-LRTI
  4. Reflections and insights into the possible exploitation of the study results
  5. Recommendations of VALUE-Dx on the role of rapid diagnostic tests for CA-LRTI
  6. Panel discussion on the User Requirement Specifications and the Technical Roadmap
  7. Interoperability of AMR data using OMOP: a Proof-of-Concept
  8. VALUE-Dx’s clinical algorithm for community-acquired LRTI and the way forward

The conference will end with an open panel discussion on the role of rapid diagnostics for CA-LRTI.

On-site participation in the meeting will be limited to invited delegates, but the good news is that all sessions will be livestreamed and videorecorded. A detailed programme and registration details for the livestream will be available soon. Send an email to VALUE-Dx’s project manager at david.depooter@uantwerpen.be if you wish to be kept in the loop.

Copyright - Value-Dx - Any dissemination of results must indicate that it reflects only the author's view and that the JUis not responsible for any use that may be made of the information it contains.